{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:49:37Z","timestamp":1774032577946,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":226,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.rmcr.2024.102091","type":"journal-article","created":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T13:55:29Z","timestamp":1723989329000},"page":"102091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unusual presentation of ROS1 rearranged metastatic non-small cell lung cancer"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7160-0690","authenticated-orcid":false,"given":"Lanyi Nora","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Leb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Saqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0765-7665","authenticated-orcid":false,"given":"Catherine A.","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rmcr.2024.102091_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/curroncol29020057","article-title":"ROS-1 fusions in non-small-cell lung cancer: evidence to date","volume":"29","author":"Gendarme","year":"2022","journal-title":"Curr. Oncol."},{"issue":"21","key":"10.1016\/j.rmcr.2024.102091_bib2","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer","volume":"371","author":"Shaw","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.rmcr.2024.102091_bib3","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/cam4.2972","article-title":"First-line crizotinib versus platinum-pemetrexed chemotherapy in patients with advanced ROS1-rearranged non-small-cell lung cancer","volume":"9","author":"Shen","year":"2020","journal-title":"Cancer Med."},{"issue":"12","key":"10.1016\/j.rmcr.2024.102091_bib4","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/annonc\/mdz407","article-title":"Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcS\u00e9 phase II trial","volume":"30","author":"Moro-Sibilot","year":"2019","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.rmcr.2024.102091_bib5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jtho.2018.07.001","article-title":"The incidence of brain metastases in stage IV ROS1-rearranged non-small cell lung cancer and rate of central nervous system progression on crizotinib","volume":"13","author":"Patil","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"10","key":"10.1016\/j.rmcr.2024.102091_bib6","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-15-2013","article-title":"A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer","volume":"22","author":"Drilon","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.rmcr.2024.102091_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa2302299","article-title":"Repotrectinib in ROS1 fusion\u2013positive non\u2013small-cell lung cancer","volume":"390","author":"Drilon","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmcr.2024.102091_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamaoncol.2015.4482","article-title":"Association between younger age and targetable genomic alterations and prognosis in non\u2013small-cell lung cancer","volume":"2","author":"Sacher","year":"2016","journal-title":"JAMA Oncol."},{"issue":"12","key":"10.1016\/j.rmcr.2024.102091_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123111","article-title":"Sex differences in lung cancer","volume":"15","author":"May","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.rmcr.2024.102091_bib10","first-page":"758","article-title":"Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers","volume":"5","author":"Lee","year":"2013","journal-title":"J. Thorac. Dis."},{"issue":"18","key":"10.1016\/j.rmcr.2024.102091_bib11","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1002\/cncr.27409","article-title":"Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer","volume":"118","author":"Doebele","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.rmcr.2024.102091_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13244-022-01200-z","article-title":"Differential diagnosis of localized pneumonic-type lung adenocarcinoma and pulmonary inflammatory lesion","volume":"13","author":"Li","year":"2022","journal-title":"Insights Imaging"},{"issue":"3","key":"10.1016\/j.rmcr.2024.102091_bib13","first-page":"183","article-title":"Delays in the diagnosis of lung cancer","volume":"3","author":"Ellis","year":"2011","journal-title":"J. Thorac. Dis."},{"issue":"11","key":"10.1016\/j.rmcr.2024.102091_bib14","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.rmcr.2024.102091_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1200\/JOP.18.00035","article-title":"Molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: American society of clinical oncology endorsement summary of the college of American pathologists\/international association for t","volume":"14","author":"Kalemkerian","year":"2018","journal-title":"J Oncol Pract"},{"issue":"3","key":"10.1016\/j.rmcr.2024.102091_bib16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.21037\/jtd-20-3075","article-title":"Prognostic value of symptoms at lung cancer diagnosis: a three-year observational study","volume":"13","author":"Polanco","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"March","key":"10.1016\/j.rmcr.2024.102091_bib17","article-title":"Detection of lung carcinoma arising from ground glass opacities (GGO) after 5 years - a retrospective review","volume":"196","author":"Herskovitz","year":"2022","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102091_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1148\/radiol.12120240","article-title":"Radiologic implications of the 2011 classification of adenocarcinoma of the lung","volume":"266","author":"Austin","year":"2013","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.rmcr.2024.102091_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/JTO.0b013e3181d60ff5","article-title":"A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice","volume":"5","author":"Casali","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.rmcr.2024.102091_bib20","article-title":"High incidence of EGFR mutations in pneumonic-type non-small cell lung cancer","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.rmcr.2024.102091_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00330-015-3814-0","article-title":"CT radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer","volume":"26","author":"Rizzo","year":"2016","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102091_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12880-016-0175-3","article-title":"CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis","volume":"17","author":"Cheng","year":"2017","journal-title":"BMC Med. Imag."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102091_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1148\/radiol.14140848","article-title":"Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation","volume":"275","author":"Choi","year":"2015","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.rmcr.2024.102091_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.lungcan.2014.09.007","article-title":"Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?","volume":"86","author":"Halpenny","year":"2014","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.rmcr.2024.102091_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00063","article-title":"Patterns of metastatic spread and mechanisms of resistance to crizotinib in ROS1-positive non\u2013small-cell lung cancer","author":"Gainor","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"10.1016\/j.rmcr.2024.102091_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.lungcan.2015.09.018","article-title":"From genotype to phenotype: are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?","volume":"90","author":"Plodkowski","year":"2015","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.rmcr.2024.102091_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cllc.2019.10.006","article-title":"Computed tomography imaging features and distribution of metastases in ROS1-rearranged non-small-cell lung cancer","volume":"21","author":"Digumarthy","year":"2020","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.rmcr.2024.102091_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.lungcan.2017.10.015","article-title":"Radiomics and radiogenomics in lung cancer: a review for the clinician","volume":"115","author":"Thawani","year":"2018","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.rmcr.2024.102091_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep41674","article-title":"Predictive radiogenomics modeling of EGFR mutation status in lung cancer","volume":"7","author":"Gevaert","year":"2017","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.rmcr.2024.102091_bib30","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/1078-0432.CCR-12-2851","article-title":"Molecular pathways: ROS1 fusion proteins in cancer","volume":"19","author":"Davies","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.rmcr.2024.102091_bib31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jtho.2020.01.019","article-title":"Optimizing mutation and fusion detection in NSCLC by sequential DNA and RNA sequencing","volume":"15","author":"Cohen","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.rmcr.2024.102091_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10080521","article-title":"Next generation sequencing for gene fusion analysis in lung cancer: a literature review","volume":"10","author":"Bruno","year":"2020","journal-title":"Diagnostics"},{"issue":"15","key":"10.1016\/j.rmcr.2024.102091_bib33","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","article-title":"High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with No mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden","volume":"25","author":"Benayed","year":"2019","journal-title":"Clin cancer Res an Off J Am Assoc Cancer Res."},{"issue":"11","key":"10.1016\/j.rmcr.2024.102091_bib34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.20.03025","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small-cell lung cancer","volume":"39","author":"Dziadziuszko","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221300712400114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221300712400114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T05:07:16Z","timestamp":1726636036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221300712400114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":34,"alternative-id":["S221300712400114X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2024.102091","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unusual presentation of ROS1 rearranged metastatic non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2024.102091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102091"}}